D.E. Shaw & Co’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,871
| Closed | -$70K | – | 4550 |
|
|
2022
Q1 | $70K | Buy |
+1,871
| New | +$70K | ﹤0.01% | 3809 |
|
|
2021
Q4 | – | Sell |
-2,240
| Closed | -$162K | – | 4295 |
|
|
2021
Q3 | $162K | Sell |
2,240
-659
| -23% | -$47.7K | ﹤0.01% | 3298 |
|
|
2021
Q2 | $278K | Sell |
2,899
-1,913
| -40% | -$183K | ﹤0.01% | 3132 |
|
|
2021
Q1 | $711K | Buy |
4,812
+2,754
| +134% | +$407K | ﹤0.01% | 2352 |
|
|
2020
Q4 | $288K | Buy |
+2,058
| New | +$288K | ﹤0.01% | 2466 |
|
|
2016
Q2 | – | Sell |
-130
| Closed | -$167K | – | 2724 |
|
|
2016
Q1 | $167K | Buy |
+130
| New | +$167K | ﹤0.01% | 2423 |
|